| RS2538630404 |
VARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS2538634781 |
PHYH
|
Health Risk |
Pathogenic |
— |
| RS2538634829 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538635051 |
PHYH
|
Health Risk |
Pathogenic |
— |
| RS2538635081 |
PHYH
|
Health Risk |
Pathogenic |
— |
| RS2538635253 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538635262 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538635317 |
PHYH
|
Health Risk |
Likely pathogenic |
— |
| RS2538635322 |
PHYH
|
Health Risk |
Likely pathogenic |
— |
| RS2538636884 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538637096 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538637344 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538639034 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538639222 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538639267 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538640575 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538640589 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive |
| RS2538640687 |
GRIN1
|
Health Risk |
Likely pathogenic |
GRIN1-related disorder, GRIN1-related disorder |
| RS2538640700 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538640791 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538640828 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2538640861 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538642532 |
RET
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2538642665 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538643445 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538643461 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538643520 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538643559 |
PHYH
|
Health Risk |
Pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538647858 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538647926 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538648271 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538649199 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538649259 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538649281 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538649313 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2538650601 |
PHYH
|
Health Risk |
Pathogenic |
— |
| RS2538650629 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538650783 |
PHYH
|
Health Risk |
Pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538651561 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538652467 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538652500 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2538653013 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538653083 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2538653190 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538653415 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538654287 |
CARD9
|
Health Risk |
Likely pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS2538654464 |
KIF1A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2538655091 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538655957 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538656489 |
PHYH
|
Health Risk |
Likely pathogenic |
— |
| RS2538656659 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538656824 |
TSC1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2538658112 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538658265 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538658624 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538658638 |
CARD9
|
Health Risk |
Pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS2538658686 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538658717 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538659131 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538659178 |
TSC1
|
Health Risk |
Pathogenic |
— |
| RS2538660511 |
EHMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2538661360 |
VARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS2538662258 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, hypocalcification type |
| RS2538663458 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2538663573 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, hypocalcification type |
| RS2538663853 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2538664377 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538665084 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS2538665254 |
NR5A1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2538665837 |
CARD9
|
Health Risk |
Pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS2538669014 |
CARD9
|
Health Risk |
Pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS2538669304 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538670229 |
PHYH
|
Health Risk |
Likely pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS2538670275 |
PHYH
|
Health Risk |
Pathogenic |
— |
| RS2538670981 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2538673493 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS2538674041 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538674045 |
NR5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Oligosynaptic infertility, 46 |
| RS2538674111 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS2538675033 |
VARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2538675310 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2538676331 |
NR5A1
|
Health Risk |
Likely pathogenic |
NR5A1-related disorder, NR5A1-related disorder |
| RS2538676383 |
NR5A1
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS2538676471 |
NR5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
NR5A1-related disorder, NR5A1-related disorder |
| RS2538676475 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY disorder of sex development |
| RS2538677887 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538678370 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538679004 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2538681872 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538683535 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY disorder of sex development |
| RS2538683556 |
NR5A1
|
Health Risk |
Likely pathogenic |
— |
| RS2538683564 |
NR5A1
|
Health Risk |
Pathogenic |
NR5A1-related disorder, 46 |
| RS2538683847 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS2538683958 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS2538683985 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS2538684217 |
NR5A1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2538684736 |
NR5A1
|
Health Risk |
Likely pathogenic |
NR5A1-related disorder, NR5A1-related disorder |
| RS2538684764 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY disorder of sex development |
| RS2538685511 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2538687051 |
NR5A1
|
Health Risk |
Likely pathogenic |
Oligosynaptic infertility, 46 |